Kerrisdale Advisers’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-181,756
Closed -$11.4M 41
2016
Q2
$11.4M Sell
181,756
-325,082
-64% -$20.1M 3.09% 12
2016
Q1
$31.8M Buy
506,838
+99,209
+24% +$6.12M 5.43% 6
2015
Q4
$27.8M Buy
407,629
+141,517
+53% +$9.21M 7.1% 3
2015
Q3
$16.5M Buy
266,112
+167,058
+169% +$11.2M 4.79% 7
2015
Q2
$6.37M Buy
+99,054
New +$6.67M 2.18% 14

Other funds holding PRXL

Kerrisdale Advisers's PRXL Position: Q3 2016 in Review

Kerrisdale Advisers sold out of Parexel International Corp (PRXL) in Q3 2016, closing a stake of 181,756 shares — an estimated $11.4M sold.

Kerrisdale Advisers first reported a position in PRXL in Q2 2015 and held it in 5 quarters. The position peaked at $31.8M in Q1 2016. 310 funds tracked by Wall St. Rank hold PRXL as of Q3 2016.

  • Kerrisdale Advisers reported no remaining Parexel International Corp position as of Q3 2016 after selling out during the quarter.
  • Kerrisdale Advisers sold 181,756 Parexel International Corp shares in Q3 2016, an estimated $11.4M.
  • Kerrisdale Advisers first reported a position in Parexel International Corp in Q2 2015 and held it in 5 quarters.
  • Kerrisdale Advisers's Parexel International Corp position peaked at $31.8M in Q1 2016.
  • 310 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2016.

Based on Kerrisdale Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.